Imeik Technology Development Co., Ltd. engages in the research, development, production and sale of biomedical materials and biopharmaceuticals. Its products include sodium hyaluronate fillers, sodium hyaluronate composite solution, facial implant threads, and medical cosmetic skin care products. The company was founded on June 9, 2004 and is headquartered in Beijing, China.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company